Visceral leishmaniasis is a chronic disease caused by Leishmania infantum. We aimed to detect the parasite in the brain of fifteen naturally-infected dogs using in situ hybridization and immunohistochemistry, and the gene expression of selected chemokines by RT-qPCR. We detected no parasite in the brain, but perivascular deposition of parasite DNA and IgG in the choroid plexus. We noticed up-regulation of CCL-3, CCL-4 and CCL-5, coherent with T lymphocyte accumulation, stating the brain as a pro-inflammatory environment. Indeed, not necessarily the parasite itself, but rather its DNA seems to act as a trigger to promote brain inflammation during visceral leishmaniasis.
Introduction
Visceral leishmaniasis (VL) is a chronic disease caused by parasitic protozoans from the Leishmania donovani complex, namely L. (L.) donovani and Leishmania (L.) infantum (syn = chagasi), which belong to the family Trypanosomatidae. Dogs are considered the main urban reservoir of this neglected disease, which presents worldwide distribution, and a zoonotic importance in Brazil and in the Mediterranean basin (Baneth et al., 2008; Chappuis et al., 2007) .
Infected dogs present with different patterns of immune response against the parasite, with an effective cellular activation or a deleterious humoral response (Barbiéri, 2006) . Infected dogs may keep asymptomatic for long periods or quickly develop the classical symptoms of the disease such as skin and ocular diseases, renal failure, anemia, cachexia and generalized lymphadenopathy (Alvar et al., 2004) . Despite the predilection for the liver, spleen and bone marrow, the parasite could virtually spread everywhere, including the genital system (Diniz et al., 2005) , muscles (Gomes et al., 2012) , and the central nervous system (Márquez et al., 2013) .
Specifically in the brain, the parasite is not often detected (Márquez et al., 2013; Viñuelas et al., 2001) , however, inflammatory lesions even in the absence of the parasite are commonly observed, predominantly leptomeningitis and choroitis, with accumulation of mononuclear cells (Ikeda et al., 2007; Nieto et al., 1996; Viñuelas et al., 2001) . For the occurrence of leukocyte migration from blood to the brain, chemokines are key molecules. They compose a superfamily of low molecular weight proteins (8-10 kDa), which act in the immune response, mainly activation and guidance of leukocyte traffic (chemotaxis) (Bendall, 2005; Mantovani, 1999) .
Chemokines are divided in four subfamilies, according to the position of cysteine residues: CXC (α-chemokines), CC (β-chemokines), C and CX3C (Mantovani, 1999; Peeters et al., 2006) . Among the β-chemokines there are MCPs (monocyte chemoattractant proteins) -1 and -2 (or CCL-2 and CCL-8, respectively); MIPs (macrophage inflammatory proteins) -1α and -1β (or CCL-3 and CCL-4, respectively); and RANTES (regulated on activation, normal T cell expressed and secreted, or CCL-5), which are highly chemoattractive to monocytes/macrophages, several lymphocytes subsets, dendritic cells and NK cells (Bendall, 2005; Rabin, 2003) .
A major representative of α-chemokines is CXCL-10 (interferon gamma-induced protein 10, or IP-10), which main function is to regulate effector Th1 cell migration to the site of inflammation during adaptive immune response (Bendall, 2005; Murphy, 2003) . Further, CX3CL-1 (fractalkine) is the only chemokine belonging to the CX3C subfamily. It acts as a chemoattractant and as an adhesion molecule, since it is present in both soluble and membrane-anchored forms. CX3CL-1 is 
